companydata.dkcompanydata.dk

Sunrise Medical ApS: Financial statements 2023

CVR: 37005665

Source: annual report 2023, Danish Business Authority

01/07/2022 – 30/06/2023

Sunrise Medical ApS (CVR 37005665) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 11,738,848 and a net result of DKK 1,408,512 compared with DKK 857,415 the year before. That is an increase of 8.6% compared with the year before. Equity in the 2023 report amounted to DKK 4,665,771. The solvency ratio was 31.4%. The company had 16 employees in the financial year.

Gross Profit
DKK 11,738,848
Profit/Loss
DKK 1,408,512
Equity
DKK 4,665,771
Total Assets
DKK 14,866,880
Employees
16

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-11.7M1.4M4.7M16
2022-10.8M857K3.3M16
2021-10M-622K2.4M16
2020-8.9M-3.3M3M19
2019-10.9M-2.8M3.5M20

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

About Sunrise Medical ApS

Sunrise Medical ApS is a Danish company of the type Anpartsselskab based in Taastrup, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Adrian John Platt and James Louis Barratt. The board consists of Adrian John Platt (chair) and James Louis Barratt. The company is owned by Cidron Ollopa B.V.. The company has 22 employees (2026). In 2024, the company reported a gross profit of DKK 12,726,030 and a net result of DKK 1,921,194 compared with DKK 1,408,512 the year before. Equity in the 2024 report amounted to DKK 6,586,965.

Source: annual report 2024, Danish Business Authority